Brokerages Set Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) PT at $64.67
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) has earned an average recommendation of “Moderate Buy” from the ten ratings firms that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and nine have issued a buy rating on the company. The average 1-year target price […]
More Stories
Funko (NASDAQ:FNKO) Sets New 12-Month High – Here’s What Happened
Funko, Inc. (NASDAQ:FNKO – Get Free Report) shares hit a new 52-week high on Thursday . The stock traded as...
Deutsche Börse (OTCMKTS:DBOEY) Share Price Passes Below Fifty Day Moving Average – Here’s Why
Deutsche Börse AG (OTCMKTS:DBOEY – Get Free Report)’s share price crossed below its 50-day moving average during trading on Tuesday...
Sprott Gold Miners ETF (NYSEARCA:SGDM) Stock Crosses Below 50 Day Moving Average – What’s Next?
Sprott Gold Miners ETF (NYSEARCA:SGDM – Get Free Report) passed below its 50 day moving average during trading on Tuesday...
Hudson’s Bay (OTCMKTS:HBAYF) Stock Price Crosses Above Fifty Day Moving Average – Should You Sell?
Hudson’s Bay Co (OTCMKTS:HBAYF – Get Free Report) shares passed above its fifty day moving average during trading on Tuesday...
Boyd Group Income Fund (OTCMKTS:BFGIF) Shares Cross Below Fifty Day Moving Average – Here’s What Happened
Boyd Group Income Fund (OTCMKTS:BFGIF – Get Free Report)’s stock price crossed below its 50-day moving average during trading on...
Duckhorn Portfolio Completes Merger and Financial Arrangements
The Duckhorn Portfolio, Inc., a Delaware corporation, recently underwent a significant corporate event detailed in an 8-K filing with the...